Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | +14.17% | +14.64% | -23.33% |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Daniel Geffken
DFI | Director of Finance/CFO | 67 | 20-10-31 |
Ali Hariri
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-07 |
Barbara Ryan
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Rubin
BRD | Director/Board Member | 63 | 14-04-30 |
Alan Walts
BRD | Director/Board Member | 64 | 21-03-31 |
Sumit Aggarwal
CEO | Chief Executive Officer | - | 21-03-31 |
Lindsay Androski
BRD | Director/Board Member | - | 22-07-04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,143,390 | 3,006,085 ( 95.63 %) | 0 | 95.63 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.33% | 2.66M | |
-2.35% | 103B | |
+1.81% | 95.28B | |
+1.46% | 22.15B | |
-15.57% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.06% | 16.05B | |
+5.25% | 13.68B | |
+35.12% | 12.17B |
- Stock Market
- Equities
- ELOX Stock
- Company Eloxx Pharmaceuticals, Inc.